Clinical Trial Update: Thalidomide in Treating Patients With Gynecologic Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 study of thalidomide in patients with gynecologic sarcomas, including endometrial cancer, has completed with results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Sarcoma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: New York University Cancer Institute | Conditions: Endometrial Cancer, Sarcoma | Phase 2 | Status: COMPLETED